University of California San Francisco Give to UCSF

Archived Content: This historical record is not updated. To request an accessible version of this page or its resources, contact calendar@ucsf.edu.

 

Perioperative Therapies in High Risk Localized Prostate Cancer

State of the Art: High Risk Localized and Oligometastatic Prostate Cancer (Moderator, Eric Small, MD)

  • Ivan de Kouchkovsky, MD
    Neoadjuvant Approaches to High Risk Localized Prostate Cancer: What We Can Learn from PROTEUS
  • Steven Seyedin, MD
    Radiation Therapy Approaches to High Risk Localized Prostate Cancer: What We Can Learn from STAMPEDE and ENZARAD
  • Cornelia Ding, MD, PhD
    Defining High Risk Localized Prostate Cancer Pathologically: New and Emerging Biomarkers of Risk
  • Carissa Chu, MD
    The UCSF Neoadjuvant Study Pipeline: Lessons Learned from Prior and Current Studies, and Next Gen Trials in Development

Correlatives, Opportunities and Prospects (Moderator, Carissa Chu, MD)

  • Matthew Cooperberg, MD, MPH
    Identifying High Risk Localized Prostate Cancer Using Contemporary and Next Gen Risk Stratification Tools
  • David Oh, MD, PhD
    Neoadjuvant Immunotherapy Trials in Prostate Cancer: Lessons Learned and Future Opportunities
  • Will Chen, MD
    Embedding Spatial Proteomics in Neoadjuvant Approaches

Next Steps: Panel Discussion and Q&A (Moderator, Peter Carroll, MD, MPH)

  • Rahul Aggarwal, MD
  • Will Chen, MD
  • Carissa Chu, MD
  • Matthew Cooperberg, MD, MPH
  • Ivan de Kouchkovsky, MD
  • Cornelia Ding, MD, PhD
  • David Oh, MD, PhD
  • Steven Seyedin, MD
  • Eric Small, MD

This workshop is open to the UCSF cancer research community. For details, please RSVP.

This is not a public event.

Event Details

UCSF promotes the exchange of diverse ideas and perspectives, acknowledging that the views and opinions of our guest speakers on campus are their own and may not reflect the perspective of the University. We embrace free speech in the pursuit of greater understanding, consistent with our obligations as a public university under the First Amendment.